期刊文献+

静脉注射帕瑞昔布联合股神经阻滞用于老年病人膝关节置换术后镇痛及膝关节功能康复的效果 被引量:16

Efficacy of intravenous parecoxib combined with femoral nerve block for postoperative analgesia and knee functional rehabilitation in elderly patients following total knee replacement
原文传递
导出
摘要 目的评价静脉注射帕瑞昔布联合股神经阻滞用于老年病人膝关节置换术后镇痛及膝关节功能康复的效果。方法拟在全身麻醉下行单侧膝关节置换术老年病人40例,ASA分级Ⅱ级,年龄65。74岁,体重45~90k,采用随机数字表法,将其随机分为2组:单纯股神经阻滞组(FNB组,n=20)和股神经阻滞联合间断静脉注射帕瑞昔布组(FNB-Pa组,n=20)。FNB组术毕时通过股神经阻滞导管注入0.25%罗哌卡因25ml镇痛,每8h给药1次,至术后72h;FNB-Pa组在术毕前30min、术后12、24、48h分别静脉注射帕瑞昔布40mg;股神经阻滞用药同FNB组,至术后72h。于术后2、12、24、36、48及72h时记录静态时VAS评分,并于术后36、48及72h时记录动态时VAS评分。于术前、术后24、48及72h对患膝关节功能进行评分(HSS评分);并记录有关不良反应的发生情况。结果FNB—Pa组术后静态、动态时VAS评分均比FNB组明显降低(P〈0.05)。与术前比较,术后两组病人HSS评分均明显提高(P〈0.05或0.01);FNB-Pa组术后48、72hHSS评分明显高于FNB组(P〈0.05)。两组均未见有关不良反应发生。结论股神经阻滞联合间断静脉注射帕瑞昔布,可安全、有效地缓解老年病人膝关节置换术后静态和动态时疼痛,有助于术后关节功能的康复。 Objective To investigate the efficacy of intravenous parecoxib combined with femoral nerve block on postoperative analgesia and knee functional rehabilitation in elderly patients following total knee replacement. Methods Forty elderly patients with osteoarthritis scheduled for total knee arthroplasty under general anesthesia, aged 65-74 years, weighing 45-90 kg, ASA Ⅱ , were randomly divided into two groups ( n = 20 each). FNB group received femoral nerve blockade for postoperative analgesia (local injection of 0.25 % ropivacaine 25 ml at the end of surgery, repeated every 8 h up to 72 h after surgery). FNB-Pa group received the femoral nerve blockade plus the parecoxib (administered IV bolus of 40 mg 30 min before the end of surgery, 12, 24, and 48 h after surgery respectively). Pain was scored at rest or during continuous passive motion using Visual Analog Scale (VAS). The Hospital for Special Surgery (HSS) knee score was determinated before surgery, at 24, 48 and 72 h after surgery respectively. Side effects were also recorded in both groups. Results VAS score was significantly lower at rest and during continuous passive motion in FNB-Pa group than in FNB group (P 〈 0.05). Compared with baseline value, HSS score increased significantly during postoperative analgesia in both groups( P 〈 0.05 or 0.01). HSS score were significantly higher at 48 h and 72 h after surgery in FNB-Pa group than in FNB group ( P 〈 0.05). No severe related side effects occured in both groups. Conclusion Femoral nerve block in combination with intravenous parecoxib can safely and effectively relieve the static and dynamic pain after total knee replacement and is helpful for rehabilitation of the prosthesis knee joint function after surgery.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2011年第8期929-931,共3页 Chinese Journal of Anesthesiology
关键词 环加氧酶抑制药 股神经 神经传导阻滞 关节成形术 置换 疼痛 手术后 镇痛 Cyclooxygenase inhibitors Femoral nerve Nerve block Arthroplasty, replacement, knee Pain, postoperative Analgesia
  • 相关文献

参考文献10

  • 1Capdevila X,Barthelet Y,Biboulet P,et al.Effects of perioperative analgesic technique on the surgical outcome and duration of rehabilitation after major knee surgery.Anesthesiology,1999,91(1):8-15.
  • 2Sundarathiti P,Ruananukul N,Channum T,et al.A comparison of continuous femoral nerve block (CFNB) and continuous epidural infusion (CEI) in postoperative analgesia and knee rehabilitation after total knee arthroplasty (TKA).J Med Assoc Thai,2009,92(3):328-334.
  • 3Barrington MJ,Olive D,Low K,et al.Continuous femoral nerve blockade or epidural analgesia after total knee replacement:a prospective randomized controlled trial.Anesth Analg,2005,101 (6):1824-1829.
  • 4Fowler SJ,Symons J,Sabato S,et al.Epidural analgesia compared with peripheral nerve blockade after major knee surgery:a systematic review and meta-analysis of randomized trials.Br J Anaesth,2008,100(2):154-164.
  • 5Duarte VM,Fallis WM,Slonowsky D,et al:Effectiveness of femoral nerve blockade for pain control after total knee arthroplasty.J Perianesth Nurs,2006,21(5):311-316.
  • 6Zaric D,Boysen K,Christiansen C,et al.A comparison of epidural analgesia with combined continuous femoral-sciatic nerve blocks after total knee replacement.Anesth Analg,2006,102(4):1240-1246.
  • 7Kardash K,Kickey D,Tesaler MJ,et al.Obturator versus femoral nerve block for analgesia after total knee arthroplasty.Anesth Analg,2007,105 (3):853-858.
  • 8吴新民,岳云,张利萍,王俊科,艾登滨,于布为,薛张纲,黄文起.术后镇痛中帕瑞昔布钠对吗啡用量的节俭作用和安全性—前瞻性、多中心、随机、双盲、安慰剂对照、平行分组研究[J].中华麻醉学杂志,2007,27(1):7-10. 被引量:367
  • 9Slupik A,Bialoezewski D.Comparative analysis of clinical usefulness of the Staffelstsin Score and the Hospital for Special Surgery Knee Score (HSS) for evaluation of early results of total knee arthroplasties:preliminary report.Ortop Traumatol Rehabil,2007,9 (6):627-635.
  • 10Talley JJ,Bertenshaw SR,Brown DL,et al.N[[5-methyl-3-phenylisoxazol-4-yi)-phenyl]sulfonyl]propanamide,sodium salt,parecoxib sodium:a potent and selective inhibitor of COX-2 for parenteral administration.J Med Chem,2000,43(9):1661-1663.

二级参考文献11

  • 1McArdle P. Intravenous analgesia. Crit Care Clin, 1999,15:89-104.
  • 2Bowdle TA. Adverse effects of opioid agonists and agonist-antagonists in anesthesia. Drug Saf, 1998,19:173-189.
  • 3Kehlet H, Dahl JB. The value of "multimodal" or "balanced analgesia"in postoperative pain treatment. Anesth Analg, 1993,77:1048-1056.
  • 4Power I, Barrett S. Analgesic agents for the postoperative period: nonopioids. Surg Clin North Am, 1999,79:275-295.
  • 5Tong D, Chung F. Postoperative pain control in ambulatory surgery. Surg Clin North Am, 1999,79:401-430.
  • 6Lipsky LP, Abramson SB, Crefford L, et al. The classification of cyclooxygenase inhibitors. J Rheumatol, 1998,25:2298-2303.
  • 7Penning TD, Talley JJ, Berteushaw SR, et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenuse-2 inhihitors:identification of 4- [ 5- ( 4-methylphenyl ) -3- ( trifluoremethyl )- 1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). J Med Chem, 1997,40:1347-1365.
  • 8Tang J, Li S, White PF, et al. Effect of parecoxib, a novel intravenous cyclooxygenuse type-2 inhibitor, on the postoperative opioid requirement and quality of pain control. Anesthesiology, 2002,96: 1305-1309.
  • 9Malan TP Jr,Marsh G, Hakki SI, et al. Parecoxib sodium, a parenteral cyclooxygenuse 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty. Anesthesiology, 2003,98 :950-956.
  • 10Kranke P, Morin AM, Roewer N, et al. Patients' global evaluation of analgesia and safety of injected parecoxib for postoperative pain: a quantitative systematic review. Anesth Analg, 2004,99:797-806.

共引文献366

同被引文献250

引证文献16

二级引证文献141

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部